Similar articles

• Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass.

  Overand PT, Teply JF. Overand PT, et al. Anesth Analg. 1998 Jun;86(6):1207-9. doi: 10.1097/00000539-199806000-00012. Anesth Analg. 1998. PMID: 9620504 No abstract available.
• The use of a somatostatin analog in the treatment of refractory hypotension after cardiopulmonary bypass.

  Egener TH, Comunale ME, Leckie RS. Egener TH, et al. J Cardiothorac Vasc Anesth. 1992 Aug;6(4):458-60. doi: 10.1016/1053-0770(92)90015-y. J Cardiothorac Vasc Anesth. 1992. PMID: 1498303 No abstract available.
• Low systemic vascular resistance during cardiac surgery: case reports, brief review, and management with angiotensin II.

  Thaker U, Geary V, Chalmers P, Sheikh F. Thaker U, et al. J Cardiothorac Anesth. 1990 Jun;4(3):360-3. doi: 10.1016/0888-6296(90)90046-i. J Cardiothorac Anesth. 1990. PMID: 2131886 Review. No abstract available.
• The use of angiotensin II to treat profound hypotension in a patient taking amiodarone.

  Geary VM, Thaker UN, Chalmers PC, Sheikh F. Geary VM, et al. J Cardiothorac Anesth. 1990 Jun;4(3):364-7. doi: 10.1016/0888-6296(90)90047-j. J Cardiothorac Anesth. 1990. PMID: 2131887 No abstract available.
• Vasoplegic syndrome--the role of methylene blue.

  Shanmugam G. Shanmugam G. Eur J Cardiothorac Surg. 2005 Nov;28(5):705-10. doi: 10.1016/j.ejcts.2005.07.011. Epub 2005 Sep 6. Eur J Cardiothorac Surg. 2005. PMID: 16143539 Review.